Dataset Information

Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test).

ABSTRACT: Multiple studies, including various methods and overall limited numbers of mostly heterogeneous cases, indicate that the level of embryonic stem cell microRNAs (miRs) (e.g. 371a-3p, 372-3p, 373-3p, and 367-3p) are increased in serum at primary diagnosis of almost all testicular germ cell cancer (TGCC). Here we determine the status of three of these miRs in serum samples of 250 TGCC patients, collected at time of primary diagnosis, compared with 60 non-TGCC patients and 104 male healthy donors. The levels of miRs were measured by the robust ampTSmiR test, including magnetic bead-based miR isolation and target specific pre-amplification followed by real-time quantitative PCR (RT-qPCR) detection. Calibration is performed based on the non-human spike-in ath-miR-159a, and normalization on the endogenous control miR-30b-5p. The serum levels of miR-371a-3p, 373-3p, and 367-3p are informative to accurately detect TGCC patients, both seminomas and non-seminomas, at the time of primary diagnosis (p< 0.000). Receiver Operating Characteristic (ROC) analysis demonstrate that the Area Under the Curve (AUC) for miR-371a-3p is 0.951 (being 0.888 for miR-373-3p and 0.861 for miR-367-3p), with a sensitivity of 90%, and a specificity of 86% (positive predictive value of 94% and negative predictive value of 79%). Inclusion of miR-373-3p and 367-3p resulted in a AUC of 0.962, with a 90% sensitivity and 91% specificity. Similar results were obtained using the raw Ct data. Importantly, the results demonstrate that ampTSmiR is not suitable to detect pure teratoma as well as the precursor of TGCC, i.e., Germ Cell Neoplasia In Situ (GCNIS). The largest series evaluated so far, demonstrate that detection of the embryonic stem cell miR-371a-3p, 373-3p and 367-3p is highly informative to diagnose patients with a primary TGCC.

SUBMITTER: van Agthoven T

PROVIDER: S-EPMC5601631 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test).

van Agthoven Ton T Looijenga Leendert H J LHJ

Oncotarget 20160727 35

Multiple studies, including various methods and overall limited numbers of mostly heterogeneous cases, indicate that the level of embryonic stem cell microRNAs (miRs) (e.g. 371a-3p, 372-3p, 373-3p, and 367-3p) are increased in serum at primary diagnosis of almost all testicular germ cell cancer (TGCC). Here we determine the status of three of these miRs in serum samples of 250 TGCC patients, collected at time of primary diagnosis, compared with 60 non-TGCC patients and 104 male healthy donors. T ...[more]

PMID: 28938535

Similar Datasets

Project description:BACKGROUNDCurrent clinical management of patients with pulmonary nodules involves either repeated low-dose CT (LDCT)/CT scans or invasive procedures, yet causes significant patient misclassification. An accurate noninvasive test is needed to identify malignant nodules and reduce unnecessary invasive tests.METHODWe developed a diagnostic model based on targeted DNA methylation sequencing of 389 pulmonary nodule patients' plasma samples and then validation in 140 plasma samples independently. We tested the model in different stages and subtypes of pulmonary nodules.RESULTSA 100-feature model was developed and validated for pulmonary nodule diagnosis; the model achieved a receiver operating characteristic curve-AUC (ROC-AUC) of 0.843 on 140 independent validation samples, with an accuracy of 0.800. The performance was well maintained in (a) a 6 to 20 mm size subgroup (n = 100), with a sensitivity of 1.000 and adjusted negative predictive value (NPV) of 1.000 at 10% prevalence; (b) stage I malignancy (n = 90), with a sensitivity of 0.971; (c) different nodule types: solid nodules (n = 78) with a sensitivity of 1.000 and adjusted NPV of 1.000, part-solid nodules (n = 75) with a sensitivity of 0.947 and adjusted NPV of 0.983, and ground-glass nodules (n = 67) with a sensitivity of 0.964 and adjusted NPV of 0.989 at 10% prevalence. This methylation test, called PulmoSeek, outperformed PET-CT and 2 clinical prediction models (Mayo Clinic and Veterans Affairs) in discriminating malignant pulmonary nodules from benign ones.CONCLUSIONThis study suggests that the blood-based DNA methylation model may provide a better test for classifying pulmonary nodules, which could help facilitate the accurate diagnosis of early stage lung cancer from pulmonary nodule patients and guide clinical decisions.FUNDINGThe National Key Research and Development Program of China; Science and Technology Planning Project of Guangdong Province; The National Natural Science Foundation of China National.

Project description:BACKGROUND:There are many different types of microRNAs (miRNAs) and elucidating their functions is still under intensive research. A fundamental step in functional annotation of a new miRNA is to classify it into characterized miRNA families, such as those in Rfam and miRBase. With the accumulation of annotated miRNAs, it becomes possible to use deep learning-based models to classify different types of miRNAs. In this work, we investigate several key issues associated with successful application of deep learning models for miRNA classification. First, as secondary structure conservation is a prominent feature for noncoding RNAs including miRNAs, we examine whether secondary structure-based encoding improves classification accuracy. Second, as there are many more non-miRNA sequences than miRNAs, instead of assigning a negative class for all non-miRNA sequences, we test whether using softmax output can distinguish in-distribution and out-of-distribution samples. Finally, we investigate whether deep learning models can correctly classify sequences from small miRNA families. RESULTS:We present our trained convolutional neural network (CNN) models for classifying miRNAs using different types of feature learning and encoding methods. In the first method, we explicitly encode the predicted secondary structure in a matrix. In the second method, we use only the primary sequence information and one-hot encoding matrix. In addition, in order to reject sequences that should not be classified into targeted miRNA families, we use a threshold derived from softmax layer to exclude out-of-distribution sequences, which is an important feature to make this model useful for real transcriptomic data. The comparison with the state-of-the-art ncRNA classification tools such as Infernal shows that our method can achieve comparable sensitivity and accuracy while being significantly faster. CONCLUSION:Automatic feature learning in CNN can lead to better classification accuracy and sensitivity for miRNA classification and annotation. The trained models and also associated codes are freely available at https://github.com/HubertTang/DeepMir.

Dataset Information

Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test).

Publications

Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test).

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure